Synthetic high-density lipoproteins as targeted monotherapy for chronic lymphocytic leukemia

Chronic lymphocytic leukemia (CLL) remains incurable despite the introduction of new drugs. Therapies targeting receptors and pathways active specifically in malignant B cells might provide better treatment options. For instance, in B cell lymphoma, our group has previously shown that scavenger rece...

Descripción completa

Detalles Bibliográficos
Autores principales: McMahon, Kaylin M., Scielzo, Cristina, Angeloni, Nicholas L., Deiss-Yehiely, Elad, Scarfo, Lydia, Ranghetti, Pamela, Ma, Shuo, Kaplan, Jason, Barbaglio, Federica, Gordon, Leo I., Giles, Francis J., Thaxton, C. Shad, Ghia, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355259/
https://www.ncbi.nlm.nih.gov/pubmed/28061439
http://dx.doi.org/10.18632/oncotarget.14494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355259/
https://www.ncbi.nlm.nih.gov/pubmed/28061439
http://dx.doi.org/10.18632/oncotarget.14494

Ejemplares similares